Protein Modifications -- to increase stability.

Slides:

Advertisements

Similar presentations

Pharmacology for Anesthesia I Introduction. What is a Drug?

Advertisements

International Epidemic Honors Colloquium at UMass Boston Berkeley W. Cue, Jr. PhD UMass Boston Class of 1969 October 7, 2013.

Applications of Nanoparticles for Delivery of Therapeutic Agents Frank Jeyson Hernández Topics of Nanobiotechnology 30 June, 2004.

Department of Chemical Engineering Kutlu Ülgen, Chair RESEARCH RESOURCES: 19 faculty members  Biomolecular.

©Immunotrex Biologics 2014 CONFIDENTIAL 1 PEG Nanoparticles: Production and Drug Delivery Structure and Function Principles of the NanoKit: A Laboratory.

Polymeric Nano-Systems Used in Drug Delivery

Dr. Amira Taman, Ph.D. 1. Research in nanotechnology is rapidly progressing the development of new modalities for early diagnosis and medical treatment.

TRANSLATIONAL RESEARCH New Therapies for MS Dennis Bourdette, M.D. and Arthur A. Vandenbark, Ph.D. TCR peptide therapy Recombinant TCR ligand (RTL) therapy.

Enzymes What is it?? Enzymes are PROTEIN molecules. Protein molecules are composed of one or more amino acid chains, folded into uniquely shaped globs.

VINOD P. SHAH, PH.D. SENIOR RESEARCH SCIENTIST OFFICE OF PHARMACEUTICAL SCIENCE CENTER FOR DRUG EVALUATION AND RESEARCH FOOD AND DRUG ADMINISTRATION Pharmacy.

Drug-Like Properties: Optimizing Pharmacokinetics and Safety During Drug Discovery Li Di and Edward H. Kerns ACS Short Course.

Other Organic Compounds: Functional Groups & Polymers.

Chap. 2 Antibody Engineering: Design for Specific Applications Factors need to be considered in the design of Ab molecules 1.Specificity and affinity of.

FDA Workshop July 2003 Protein Delivery from Mechanical Devices Challenges and Opportunities Bill Van Antwerp and Poonam Gulati The Protein Formulation.

© 2014 Direct One Communications, Inc. All rights reserved. 1 Treatment of Hemophilia: What’s in the Pipeline? Kerry Hege, MD Indiana University School.

Dionicio Siegel – Accessing, Understanding, and Optimizing Compounds We are interested in: Providing synthetic access to unique compounds with promising.

Biotechnology in Medicine Chapter 12.

Ms. RIFFAT YASMIN. Objectives Discuss types of Ophthalmic Dosage forms with examples Interpret the Advantages & Disadvantages of : 1. Ophthalmic solutions.

Alcohols AS Chemistry lesson 48 Textbook reference: p Next lesson:

 Energy ◦ The ability to do work or cause change ◦ Occurs in various forms ◦ Can be converted to another form ◦ Forms important to biological systems.

Slide 1 EZT 2003-W SS Mechanism of Action and Pharmacology of Ezetimibe Copyright © 2003 MSP Singapore Company, LLC. All rights reserved.

NANOTECHNOLOGIES: THE NEW GENERATION OF MEDICINE Dr Mariano Licciardi.

1.  Drug delivery is the method or process of administering pharmaceutical compound to achieve a therapeutic effect in humans or animals.  Most common.

SCALABLE PRODUCTION OF POLYMERIC NANOPARTICLES YING LIU ASSISTANT PROFESSOR DEPARTMENT OF CHEMICAL ENGINEERING DEPARTMENT OF BIOPHARMACEUTICAL SCIENCES.

Liposomes Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel:

Formulation factors By Dr. A. S. Adebayo.

Polymeric Micelles Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel:

Erika Snow Mentoring Professor - Dr. John Mata. Caused by an airborne bacterium Tuberculosis 20/ultraviolet-light-may-curb-

Controlled drug delivery Jonathan O’Dwyer John Rasmussen CHEN 641.

DELIVERY OF PROTEINS USING BIODEGRADABLE POLYMERS Mahesh V. Chaubal Guilford Pharmaceuticals Inc. Baltimore, MD 21224

1 Controlled drug release Dr Mohammad Issa. 2 Frequency of dosing and therapeutic index  Therapeutic index (TI) is described as the ratio of the maximum.

Abstract Polymeric Porous microspheres are an effective drug delivery mechanism able to control drug release, preventing drug wastage and lowering costs.

Liposomes are spherical vesicles composed of a membrane surrounding an aqueous core. Liposomes are used for drug delivery (in the form of genes, peptides,

© Paradigm Publishing, Inc.1 Chapter 2 Basic Concepts of Pharmacology.

Enzymes AP Biology. General Information Globular proteins Unique 3 dimensional shape Active site: pocket or groove where substrate binds.

Dr. Muslim Suardi, MSi., Apt. Faculty of Pharmacy, University of Andalas.

Modern aspects of drugs production. Differences.

Introduction to Pharmacology Yacoub Irshaid MD, PhD, ABCP Department of Pharmacology.

Principles of Drug Action

BIOLOGY Protein Structure and Enzymes. What is an Enzyme? Known as a BIOLOGICAL CATALYST Catalyst is something that speeds up a chemical reaction Biological.

Proteins - made of H, O, C, and N - formed by linking monomers called amino acids. - most important organic compound – body structure Amino Acids - 20.

Lessons Learned from Standard of Care, First Generation and Next Generation Biotherapeutics: What Do We Expect to Change Going Forward ? Steven J Swanson,

Basic Concepts of Pharmacology © Paradigm Publishing, Inc.

Advantages of Good Drug-like Properties 손한표.

Drug discovery involves systematically identifying which protein is causing a problem in the body - either because it is absent, defective, or excessive.

© 2016 Global Market Insights, Inc. USA. All Rights Reserved Fuel Cell Market size worth $25.5bn by 2024Low Power Wide Area Network.

Vision Center of excellence in pharmaceutical, delivery, device technology Incubator of technologies, companies, and talent Provider of formulation, delivery.

Chap. 2 Antibody Engineering: Design for Specific Applications

Nivolumab Drugbank ID : DB09035 Molecular Weight (Daltons) :

Chemical and Biomedical Engineering

KJ Hansen, JK Simons, TA Peterson

Biopharmaceutics of modified release drug products

Controlled drug release

Novel Drug Delivery System

Antibody domain Single domain antibodies represent the smallest antibody that was proven of diagnostic and therapeutic usefulness. They are antibody fragments.

Drug Affinity Responsive Target Stability (DARTS).

PEGylation Products and Services Profacgen. Introducing polyethylene glycol (PEG) to biomolecules and pharmaceuticals is known to enhance stability and.

Non-PEGylated Liposome Production Non-PEGylated Liposome Production —Creative Biostructure.

الاحتراق.

Pegylated interferons

Proteins and Enzymes 2:3.

Scientific Drivers Technology in Development Issues Viral vectors

Pharmacokinetics and Pharmacodynamics of Peptide and Protein Drugs

Introduction to Pharmacology

Pharmacokinetics.

Denis Jullien, Jörg C. Prinz, Frank O. Nestle

Proteins and Enzymes 2:3.

US Army Medical Research and Materiel Command

A change in either volume of distribution or clearance has differing effects on the concentration-time profile. A change in either volume of distribution.

Chemistry of Living Things

Presentation transcript:

Protein Modifications -- to increase stability

Goal of protein modification Improved bioavailability, including longer circulation time and slower clearance Optimized pharmacokinetics resulting in sustained durationpharmacokinetics Improved safety profile with lower toxicity, immunogenicity, and antigenicity immunogenicityantigenicity Increased efficacy Decreased dosing frequency Improved drug solubility and stability Reduced proteolysis Controlled drug release

In an aqueous medium, the long, chain-like PEG molecule is heavily hydrated and in rapid motion. This rapid motion causes the PEG to sweep out a large volume and prevents the approach and interference of other molecules. As a result, when attached to a drug, PEG polymer chains can protect the drug molecules from immune response and other clearance mechanisms, sustaining drug bioavailability

Four-Armed Functional PEG

Eight-Arm Functional PEG

Comb-Shaped Copolymers

Chemistry for peptide and protein PEGylation * M.J. Roberts, M.D. Bentley, J.M. Harris Advanced Drug Delivery Reviews 54 (2002) 459–476 PEG-proteins: Reaction engineering and separation issues Chemical Engineering Science 61 (2006) 924 – 939 Conan J. Feea,., James M. Van Alstineb

Neoglycosylation Alkoxyamine-mediated neoglycosylation